Meridian to buy diagnostic bio component company:
This article was originally published in Clinica
Executive Summary
Meridian Bioscience of Cincinnati, Ohio, has agreed to acquire all outstanding capital stock of OEM Concepts, a developer of biological components used in diagnostic tests. These monoclonal antibodies, which generated over $4m in revenues for Toms-River, New Jersey-based OEM, are form an important component in diagnostic tools for infectious diseases and for monitoring metabolic disorders, pregnancy and cardiac disease. The transaction, which involves a mix of cash and milestone payments, is expected to close within 60-90 days.
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.